SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PAVAN, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.569
EU - Europa 1.950
AS - Asia 1.091
SA - Sud America 10
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.562
CN - Cina 691
UA - Ucraina 562
IT - Italia 346
TR - Turchia 307
DE - Germania 303
GB - Regno Unito 232
PL - Polonia 162
SE - Svezia 138
FI - Finlandia 118
VN - Vietnam 36
FR - Francia 30
RU - Federazione Russa 21
HK - Hong Kong 18
IN - India 16
AT - Austria 7
BE - Belgio 7
IR - Iran 6
NL - Olanda 6
BR - Brasile 5
CA - Canada 5
CZ - Repubblica Ceca 4
IE - Irlanda 4
IQ - Iraq 4
PK - Pakistan 4
CH - Svizzera 3
TH - Thailandia 3
CL - Cile 2
DK - Danimarca 2
IL - Israele 2
JP - Giappone 2
RO - Romania 2
ZA - Sudafrica 2
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
EU - Europa 1
GR - Grecia 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 10.625
Salva come PNG Salva come JPEG
Città #
Fairfield 1.057
Woodbridge 1.040
Jacksonville 634
Houston 625
Chandler 527
Ashburn 483
Ann Arbor 447
Seattle 412
Wilmington 366
Cambridge 361
Izmir 231
Nanjing 177
Ferrara 170
Warsaw 162
Beijing 159
Princeton 147
Boardman 103
San Diego 96
Addison 72
Milan 59
New York 58
Hebei 51
Nanchang 49
Shenyang 48
Shanghai 44
Dong Ket 36
Bremen 31
Dearborn 29
Falls Church 28
Redwood City 28
Changsha 27
Tianjin 25
Jiaxing 24
Mountain View 23
San Mateo 23
Auburn Hills 20
London 19
Jinan 17
Kunming 17
Norwalk 17
Hong Kong 16
Orange 13
Indiana 11
Los Angeles 11
Tappahannock 11
Washington 11
Bologna 10
Des Moines 9
Augusta 8
Philadelphia 8
Brussels 7
Dallas 7
Lanzhou 7
Leawood 7
Ningbo 7
Guangzhou 6
Hangzhou 6
Rovere Veronese 6
Verona 6
Zhengzhou 6
Helsinki 5
Vienna 5
Argenta 4
Dublin 4
Hanover 4
Masi Torello 4
Redmond 4
Rome 4
Amsterdam 3
Bolzano 3
Codevigo 3
Frankfurt Am Main 3
Haikou 3
Hefei 3
Islamabad 3
Kilburn 3
Modena 3
Oberengstringen 3
Pietro 3
Taizhou 3
Torino 3
Toronto 3
Treviso 3
Acton 2
Ardabil 2
Changchun 2
Edinburgh 2
Florence 2
Hounslow 2
Innsbruck 2
Islington 2
Khorasan 2
Lappeenranta 2
Loreto 2
Monmouth Junction 2
New Bedfont 2
Paris 2
Prescot 2
Qingdao 2
San Francisco 2
Totale 8.228
Salva come PNG Salva come JPEG
Nome #
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 196
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 143
cAMP efflux from human trophoblast cell lines: A role for multidrug resistance protein (MRP)1 transporter 143
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 141
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 139
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 138
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 133
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 126
"Low" concentrations of sodium fluoride inhibit neurotransmitter release from the guinea-pig superior cervical ganglion. 125
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 121
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 119
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 119
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. 118
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 118
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 118
17 beta-estradiol stimulates arachidonate release from human amnion-like WISH cells through a rapid mechanism involving a membrane receptor 116
Conjugation of aspirin with vitamin C: uptake and stability studies 116
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 115
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 112
Adenosine analogs inhibit acetylcholine release and cyclic AMP synthesis in the guinea-pig superior cervical ganglion 112
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 112
Circadian clocks regulate adenylyl cyclase activity rhythms in human RPE cells 111
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 110
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. 109
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 109
Inhibition of amniotic interleukin-6 and prostaglandin E-2 release by ampicillin 107
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 106
Formyl-methionyl-leucyl-phenylalanine induces prostaglandin E2 release from human amnion-derived WISH cells by phospholipase C-mediated [Ca2+]i rise 104
Progress in drug delivery to the central nervous system by the prodrug approach 104
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 102
Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. 102
null 101
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 101
The role and modulation of the oxidative balance in pregnancy 100
Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice 99
Prostaglandin E-2 inhibits proliferation and migration of HTR-8/SVneo cells, a human trophoblast-derived cell line 99
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 98
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission. 98
Biochemical and pharmacological characterization of adenosine A1 receptors in eel (Anguilla anguilla) brain. 98
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: a thermodynamic analysis. 97
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 97
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 97
Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications. 95
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 95
Influence of oxytocin on prostaglandin E-2, intracellular calcium, and cyclic adenosine monophosphate in human amnion-derived (WISH) cells 94
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 94
Processing of adenosine receptor agonists in rat and human whole blood. 93
The cyclooxygenase-2/prostaglandin E2 pathway is involved in the somatostatin-induced decrease of epileptiform bursting in the mouse hippocampus. 93
null 93
Interactions between the nitric oxide and prostaglandin E2 biosynthetic pathways in human amnion-like WISH cells. 92
null 92
Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity. 91
Effect of different classes of antibiotics on amniotic prostaglandin E release 91
Adenosine enhances acetylcholine receptor channel openings and intracellular calcium 'spiking' in mouse skeletal myotubes. 90
Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release 90
Use of glucocorticoids in pregnancy. 89
Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus 86
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 86
17β-estradiol modulates prostaglandin E2 release from human amnion-derived WISH cells 86
WISH cells as a model for the "in vitro" study of amnion pathophysiology. 85
High glucose-induced barrier impairment of human retinal pigment epithelium is ameliorated by treatment with Goji berry extracts through modulation of cAMP levels. 85
null 83
Odorants could elicit repair processes in melanized neuronal and skin cells 83
null 83
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 83
Somatostatin coupling to adenylyl cyclase activity in the mouse retina 82
null 81
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 81
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 80
Inhibition of amniotic prostaglandin E release by ampicillin 78
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 77
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 74
Thermodynamic in vitro studies as a method to investigate the in vivo behaviour of adenosine A1 receptor ligands. 73
Quercetin and quercetin-3-O-glucoside interact with different components of the cAMP signaling cascade in human retinal pigment epithelial cells. 73
METODO PER MODULARE L'ASSORBIMENTO FAGOCITARIO DI UN PRINCIPIO ATTIVO O UN SUO PRECURSORE DA PARTE DI MACROFAGI 72
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 71
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 71
β-methasone, progesterone and RU-486 (mifepristone) exert similar effects on connexin expression in trophoblast-derived HTR-8/SVneo cells. 70
Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A(1) receptor ligands 70
null 70
Estrogens metabolites in the release of inflammatory mediators from human amnion-derived cells 69
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 69
Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies 68
Cross-talk between nitridergic and prostaglandinergic pathways in amnion-like WISH cells 65
Role of oxidative stress in chemical hypoxia induced apoptosis 65
Cobalt chloride induced hypoxia and lipid peroxidation in HRPE cells 63
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 62
Neuropharmaceutical agents and their pro-drug obtained by conjugation with vitamin C: studies of delivery into the brain. 62
Vitamin C prodrugs of diclophenamic acid: stability studies and uptake analysis on HRPE cells. 62
Coniugati dell’acido ascorbico ad attività neurotropica. 62
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 61
Synthesis and characterization of potential adenosine A1 receptor prodrugs 60
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 60
Conjugation of Dopamine and an A2A Adenosine Receptor Antagonist: a possible approach for the treatment of Parkinson’s Disease. 59
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 59
In vitro behaviour of N6-cyclopentyladenosine-loaded nanoparticles prepared via a non-aqueous nanoparecipitation method. 58
Stereochimica e tossicità 58
Studies for delivery into the brain of neurotropic drugs and their prodrugs conjugated with vitamin C. 57
Evidence for a circadian clock in HRPE cells controlling adenylyl cyclase activity rhythms 57
Release modulation of hydrophilic drugs from polymeric nanoparticles produced by in-oil nanoprecipitation process 57
Totale 9.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 390
Totale 40.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019965 0 0 0 0 0 0 0 0 0 0 348 617
2019/20202.556 415 94 95 368 171 286 216 293 190 272 109 47
2020/20211.824 136 134 98 165 78 186 54 207 78 332 233 123
2021/20221.315 37 174 103 50 44 47 57 65 53 99 111 475
2022/20231.254 144 65 45 154 227 191 44 98 152 8 81 45
2023/2024481 68 95 39 22 59 95 31 37 17 16 2 0
Totale 10.830